Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04967976 · ClinicalTrials.gov registry record · NA
Breast Mesh Used in Two-staged Breast Reconstruction
A NA study of Breast Cancer and Breast Reconstruction, sponsored by Tianjin Medical University Cancer Institute and Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 300
- Enrollment target
- 6
- Study locations
NCT04967976: Recruiting NA study of Breast Cancer and Breast Reconstruction, sponsored by Tianjin Medical University Cancer Institute and Hospital.
NCT04967976 is a NA study of Breast Cancer and Breast Reconstruction that is actively recruiting participants, run by Tianjin Medical University Cancer Institute and Hospital. The registered enrollment target is 300 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (89% lower). The trial reports 6 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04967976, a NA study of Breast Cancer and Breast Reconstruction, is actively recruiting participants, sponsored by Tianjin Medical University Cancer Institute and Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
- 6
- Study locations
Study Summary
This is the first prospective randomized and controlled study on the efficacy and safety of TiLOOP® Bra mesh in patients with expander-implant breast reconstruction. The investigators hypothesize that incoporating TiLOOP Bra mesh with tissue expanders will reduce the rates of capsular contraction, improve the efficiency of expansion and provide better aesthetic result.
Conditions Studied
Interventions
- PROCEDURE TiLoop Bra mesh in expander-implant breast reconstrution
- PROCEDURE sub-pectoral expander-implant breast reconstruction
Study Locations (6)
Texas
- MD Anderson Cancer Center - Houston
Gansu
- Gansu Provincial Cancer Hospital - Lanzhou
Jilin
- Jilin Cancer Hospital - Ch’ang-ch’un
Tianjin Municipality
- Tianjin Medical University Cancer Institute and Hospital - Tianjin
Zhejiang
- Zhejiang Provincial People's Hospital - Hangzhou
Other
- Technical University of Munich - Munich
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2021-08-01 |
| Est. Completion | 2026-08-01 |
| Phase | NA |
What NCT04967976 shows while recruiting
NCT04967976 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (89% lower).
The record links to 4 conditions, with Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which TiLoop Bra mesh in expander-implant breast reconstrution is the first listed.
NCT04967976 lists 6 locations in 6 states (Texas, Gansu, Jilin).
Frequently Asked Questions
What is clinical trial NCT04967976 about?
NCT04967976 is a clinical study titled "Breast Mesh Used in Two-staged Breast Reconstruction". This is the first prospective randomized and controlled study on the efficacy and safety of TiLOOP® Bra mesh in patients with expander-implant breast reconstruction. The investigators hypothesize that incoporating TiLOOP Bra mesh with tissue expanders will reduce the rates of capsular contraction, i...
What is the current status of trial NCT04967976?
This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2021-08-01. Estimated completion is 2026-08-01.
What conditions does trial NCT04967976 study?
This clinical trial studies the following conditions: Breast Cancer, Breast Reconstruction, Radiation, Synthetic Mesh.
What interventions are being tested in trial NCT04967976?
The interventions under investigation include: TiLoop Bra mesh in expander-implant breast reconstrution (PROCEDURE), sub-pectoral expander-implant breast reconstruction (PROCEDURE).
Who is sponsoring clinical trial NCT04967976?
This trial is sponsored by Tianjin Medical University Cancer Institute and Hospital, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04967976 being conducted?
This trial has 6 study locations across Texas, Gansu, Jilin, Tianjin Municipality, Zhejiang. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04967976's enrollment target sits among peer trials
300 277th of 1224 higher than 938 of 1,224 other Breast Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
RECRUITING · NA
-
A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI